8750:TSEDai-ichi Life Holdings,Inc. Analysis
Data as of 2026-06-09 - not real-time
¥1,705.50
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
Daiichi Life Group (8750.T) is trading at ¥1,705.5, comfortably above its 20‑day SMA (¥1,635.9) and 50‑day SMA (¥1,528.6), confirming a bullish price trend. However, the RSI is elevated at 71 and the MACD has turned bearish, suggesting short‑term overbought conditions near the resistance level of ¥1,732.
Fundamentally, the stock appears significantly undervalued: a forward P/E of 4.6, a trailing P/E of 14.2 versus an industry average of 16.5, and a DCF‑derived fair value around ¥10,800 point to a sizable discount. Revenue is expanding at a robust 26% YoY, earnings per share are set to triple (trailing ¥119.9 vs forward ¥369.9), and the dividend yield of 4.32% with a 45% payout ratio is well‑backed by strong operating and free cash flow. Recent corporate developments—including Protective Life’s acquisition of Obsidian and the planned CEO transition—highlight strategic growth in the U.S. market, adding further upside potential.
Fundamentally, the stock appears significantly undervalued: a forward P/E of 4.6, a trailing P/E of 14.2 versus an industry average of 16.5, and a DCF‑derived fair value around ¥10,800 point to a sizable discount. Revenue is expanding at a robust 26% YoY, earnings per share are set to triple (trailing ¥119.9 vs forward ¥369.9), and the dividend yield of 4.32% with a 45% payout ratio is well‑backed by strong operating and free cash flow. Recent corporate developments—including Protective Life’s acquisition of Obsidian and the planned CEO transition—highlight strategic growth in the U.S. market, adding further upside potential.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- RSI above 70 indicating overbought conditions
- Price approaching the ¥1,732 resistance level
- Bearish MACD histogram suggesting short‑term momentum weakening
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- DCF fair value far above current price, implying strong upside
- Revenue growth of 26% and EPS acceleration
- Attractive dividend yield with a sustainable payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Low beta (0.4) indicating defensive characteristics
- Demographic tailwinds for life insurance in Japan and expanding U.S. presence
- Consistent free cash flow generation supporting dividend compounding
Key Metrics & Analysis
Financial Health
Revenue Growth26.30%
Profit Margin4.26%
P/E Ratio14.2
ROE11.06%
ROA0.30%
Debt/Equity74.67
P/B Ratio1.4
Op. Cash Flow¥792.2B
Free Cash Flow¥1108.2B
Industry P/E16.5
Technical Analysis
TrendBullish
RSI70.9
Support¥1,474.00
Resistance¥1,732.00
MA 20¥1,635.95
MA 50¥1,528.61
MA 200¥1,344.35
MACDBearish
VolumeStable
Fear & Greed Index85.04
Valuation
Fair Value¥10,810.64
Target Price¥1,630.00
Upside/Downside-4.43%
GradeUndervalued
TypeBlend
Dividend Yield4.32%
Risk Assessment
Beta0.40
Volatility30.05%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.